Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check7 days agoChange DetectedAdded related topics: Cystic fibrosis and MedlinePlus Genetics to the related topics section.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now shows Revision: v3.4.3, and related-topic links such as Cystic Fibrosis related topics and MedlinePlus Genetics were removed.SummaryDifference0.2%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedAdded related topics links for Cystic fibrosis and MedlinePlus Genetics. These are supplementary navigation aids and do not alter core study content or decisions about participation.SummaryDifference0.2%

- Check50 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and related topics such as Cystic fibrosis and Revision: v3.4.1.SummaryDifference0.6%

- Check57 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operating status information; the page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.